Financial Calendar

  • Year-End Report: 2021-02-18
  • Q1-report: 2021-04-14
  • Annual General Meeting: 2021-04-26
  • Q2-report: 2021-08-19
  • Q3-report: 2021-11-17
  • Year-End Report: 2022-02-16
Test tubes in a lab environment
Elicera Therapeutics AB is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.

Org.nr: 556966-4955.
Elicera Therapeutics AB (publ)
World Trade Center Göteborg
Mässans gata 10, floor 7
412 51, Göteborg
info@elicera.com
+46 (0)70-331 90 51‬